• Establishing pharmacologically relevant exposure levels and engagement are two key steps in target validation. • There is a need for better biomarkers to objectively measure biological states and ...
As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...
Artificial intelligence (AI) is emerging as a transformative tool in drug discovery and development, influencing steps from target identification to clinical trial outcome analyses. Target ...
Large language models (LLMs) can be broadly applied across multiple key stages in drug development: (1) Target identification and drug screening. Llama-Gram, GPCR LLM, and ProtChat systems effectively ...
Drug development faces persistent challenges, with high attrition rates and unexpected adverse effects contributing to clinical trial failures. The recent convergence of large-scale biobanks, ...
Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...
While agents like AbbVie's Humira have transformed the treatment landscape, not all patients benefit equally from the drug.
On June 22, SK Biopharmaceuticals announced at the 2026 BIO International Convention in the United States that it had signed a research and developmen ...
Insilico Medicine & SK Biopharmaceuticals achieve AI-powered drug discovery collaboration: Massachusetts Tuesday, June 23, 2026, 14:00 Hrs [IST] Insilico Medicine, a clinical-stag ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results